Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001778623-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 18, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
90,000
Total Value
$2,960,358.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel and Sec. | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 30,000 | $17.88 | $536,400.00 | 30,000 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Jun 17, 2026 | Sale | 16,771 | $80.34 | $1,347,382.14 | 13,229 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Common Stock | โ | Jun 17, 2026 | Sale | 13,229 | $81.38 | $1,076,576.02 | 0 | Direct | โ | View Details | |
SVP, General Counsel and Sec. | Stock Option (Right to Buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 80,000 | Direct | โ | View Details |